| Literature DB >> 34831797 |
Takuma Okumura1, Koji Hara2, Ayako Nakane1, Chizuru Namiki1, Kazuharu Nakagawa1, Kohei Yamaguchi1, Kanako Yoshimi1, Mizue Toyoshima3, Yoshiyuki Sasaki4, Haruka Tohara1.
Abstract
This retrospective study determined the significant predictive factors for the number of days required to remove nasogastric tubes (NGTs) after surgery in patients with oral cancer (OC). In this study, patients underwent a videofluoroscopic swallowing study (VFSS) approximately 2 weeks after surgery. Videofluoroscopic images were analyzed, and variables such as swallowing and swallowing kinematics were measured. Patient characteristics, swallowing kinematics, and swallowing results were assessed using a Cox proportional hazards model. This study assessed 129 participants (66 men, 63 women, mean age: 69.0 ± 14.1 years) with nine types of cancer. The Cox proportional hazard ratio revealed that sex, body mass index before surgery, radiotherapy and/or chemotherapy, dysphagia before surgery, normalized pharyngeal constriction ratio, upper esophageal sphincter (UES) opening, and laryngeal vestibule disclosure (LVC) disorder were predictive factors for the removal of NGTs when adjusted for age. The study identified several predictive factors for the removal of NGTs and oral intake recovery in patients with OC. Regarding swallowing kinematics, UES opening is the most significant predictive factor. After surgery for OC, VFSS should be performed to assess safe eating methods and predict the recovery of oral intake and removal of the NGT.Entities:
Keywords: nasogastric tube; oral cancer; oral intake; swallowing kinematics; videofluoroscopic swallowing
Mesh:
Year: 2021 PMID: 34831797 PMCID: PMC8620679 DOI: 10.3390/ijerph182212045
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Baseline characteristics of patients with oral (n = 129).
| Variable | |||
|---|---|---|---|
| Sex | Male | 66 | (51.2) |
| Female | 63 | (48.8) | |
| Age | <65 | 54 | (41.9) |
| ≥65 | 75 | (58.1) | |
| BMI | <18.5 | 14 | (10.9) |
| ≥18.5 | 115 | (89.1) | |
| FOIS | 1 | 7 | (5.4) |
| 2 | 0 | (0) | |
| Stage | 3 | 0 | (0) |
| 4 | 10 | (7.8) | |
| 5 | 3 | (2.3) | |
| 6 | 18 | (14.0) | |
| 7 | 91 | (70.5) | |
| I | 10 | (7.8) | |
| II | 27 | (20.9) | |
| III | 35 | (27.1) | |
| IV | 57 | (44.2) | |
| Type of cancer | Tongue | 61 | (47.3) |
| Gingival | 44 | (34.1) | |
| Upper jaw | 11 | (8.5) | |
| Lower jaw | 33 | (25.6) | |
| Buccal mucosal | 10 | (7.8) | |
| Oral floor | 10 | (7.8) | |
| Lower jaw | 2 | (1.6) | |
| Hard plate | 1 | (0.7) | |
| Myxoma | 1 | (0.7) | |
Abbreviations: BMI, body mass index; FOIS, functional oral intake scale.
Days until removal of the nasogastric tube according to the type of cancer.
| Type of Cancer | Days until Removal of the Nasogastric Tube |
| (%) | ||
|---|---|---|---|---|---|
| Tongue | median (IQR) | 19 (16.0–25.0) | 61 | (47.3) | 0.266 |
| Gingival | median (IQR) | 18.5 (14.3–24.5) | 44 | (34.1) | |
| Upper jaw | Mean ± SD | 18.9 ± 12.0 | 11 | (8.5) | |
| Lower jaw | median (IQR) | 17.0 (15.0–24.0) | 33 | (25.6) | |
| Buccal mucosal | Mean ± SD | 25.3 ± 11.8 | 10 | (7.8) | |
| Oral floor | Mean ± SD | 20.7 ± 7.5 | 10 | (7.8) | |
| Lower jaw | 23, 28 | 2 | (1.6) | ||
| Hard plate | 30 | 1 | (0.7) | ||
| Myxoma | 14 | 1 | (0.7) | ||
| Overall | IQR | 20.5 (18.6–28.0) | 129 | (100.0) |
Abbreviations: IQR, interquartile range; SD, standard deviation p-value *: Kruskal–Wallis test adjusted with Bonferroni correction.
Predictors of days until removal of the nasogastric tube, assessed using a Cox proportional hazards model.
| Variable | Unadjusted HR | 95%CI | Adjusted HR | 95%CI | |||||
|---|---|---|---|---|---|---|---|---|---|
| Sex | (female) | 1.02 | 0.71 | 1.48 | 0.900 | 0.57 | 0.36 | 0.88 | 0.012 * |
| Age | (elderly) | 0.73 | 0.49 | 1.08 | 0.118 | 0.87 | 0.57 | 1.32 | 0.510 |
| BMI | (heavy) | 0.80 | 0.44 | 1.43 | 0.443 | 0.42 | 0.22 | 0.84 | <0.014 * |
| Dysphagia before surgery | (+) | 0.4 | 0.23 | 0.73 | <0.001 ** | 0.27 | 0.14 | 0.51 | <0.001 ** |
| CR before surgery | (+) | 0.70 | 0.47 | 1.03 | 0.073 | 0.60 | 0.38 | 0.95 | 0.03 * |
| Aspiration | (+) | 0.78 | 0.51 | 1.20 | 0.256 | 0.67 | 0.42 | 1.08 | 0.091 |
| OPD | (−) | 1.54 | 1.06 | 2.27 | 0.023 * | 0.69 | 0.43 | 1.12 | 0.141 |
| LVC | (bad) | 2.04 | 1.39 | 3.03 | <0.001 ** | 0.52 | 0.34 | 0.833 | 0.005 ** |
| PCRN | (Large amount) | 0.58 | 0.39 | 0.84 | 0.004 ** | 0.58 | 0.37 | 0.90 | 0.014 * |
| UES opening | (small amount) | 0.52 | 0.36 | 0.77 | <0.001 ** | 0.41 | 0.26 | 0.65 | <0.001 ** |
| Hyoid bone displacement | (Large amount) | 0.74 | 0.51 | 1.08 | 0.118 | 0.69 | 0.41 | 1.15 | 0.157 |
Abbreviations: HR, hazard ratio; BMI, body mass index; CR, chemotherapy and/or radiotherapy; OPD, oral phase dysphagia; PCRN, pharyngeal constriction ratio normalized; UES opening, upper esophageal sphincter; LVC, laryngeal vestibule closure. *: p < 0.05, **: p < 0.01. Note: Table 3 shows how sex, BMI before surgery, dysphagia before surgery, CR, LVC, PCRN, and UES opening affected the period until removal of the NGT.